Galantamine, a tertiary alkaloid and reversible AChE inhibitor, also has an allosteric binding mechanism at nicotinic receptors, enhancing cholinergic transmission and improving cognitive function in mild to moderate AD and mixed dementia. This evidence concerns the gene ACHE and Alzheimer disease.